Connection

Robert Gemmill to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Robert Gemmill has written about Protein Kinase Inhibitors.
Robert Gemmill
Connection Strength
0.538
Protein Kinase Inhibitors
  1. MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib. J Thorac Oncol. 2009 Apr; 4(4):472-8.
    View in: PubMed
    Score: 0.270
  2. Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2021 08; 162(2):463-473.
    View in: PubMed
    Score: 0.146
  3. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS One. 2016; 11(1):e0147344.
    View in: PubMed
    Score: 0.108
  4. Upstream signaling inhibition enhances rapamycin effect on growth of kidney cancer cells. Urology. 2007 Mar; 69(3):596-602.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.